Russia new covid cases near 5,000 cases. New cases has increased for 5 days straight. Putin tried to promote his vaccine again 2 days ago. That is bad sign that Russian vaccine efforts are failing.
hes gonna dump it soon so when it ticks up and you have earned 50% just dump. I mean unless comes winter season then covid is worse then all gloves fly but bcareful
Can the CEOs of the Big 4 and Small 3 glove companies come up together to hold news conference and give reassurance to the public that the gloves demands is still very high despite news of vaccine here and there. If the vaccine is available to the public one day, the glove supplies could not cope with the demands. Before vaccine, you need gloves for the sick; after the vaccine, u need gloves for the sick and the healthy and the healthy population in the world is thousands time higher than the sick, which means there's huge surge of gloves demand than ever before!! Pls spread this message and educate those especially the uncle aunties who have the terrible misconception about glove demands is inversely proportional to vaccination, these are the investors with money but no brain, and they are the major people that bring gloves stock price down whenever news of vaccines come out!!!
Even covid here to stay it does not mean more gloves users mah..!!
Its demand may have peaked mah...!!
Ask yourself who are the gloves users ?? Mainly medical personnels mah...!!
How many medical personnels are there leh ?? It is limited mah, it does not grow overnight loh..!! U already factor in they have more frequesnt use of gloves that means thats all loh....Demand already peaked mah...!!
Posted by kfliau > Aug 31, 2020 10:55 AM | Report Abuse
stay invested in supermx. Discard all the noises. Covid is here to stsy for a long time though not to my liking
Yes Raider is a supporter of vaccine, but if u r uncomfortable with vaccine, buying banks esp quality Pbank stand a better investment preposition than gloves loh...!!
@observers Ceos and directors are in no way mandatory to take any stance of the situation here. If lets say they do announce anythin, this will bring alot of attention to their companies and the markets as well as glove stocks are sort of a taboo/ casino market play for the past 4 months. If the stock drops alot after their announcement, alot of ppl will cry foul saying syndicate play this la that la. the best way is to let the market react itselves as it moves alongside with sentiments. if covid cases are up and no vaccine in play, theres nothin to worry about
glove fact : demand for exceed supply vaccine fact : in progress & real but final stages maybe the middle of next year, but ppl who always shout out about it only share fake & misleading info.
INCLUDING THE TOP OF 4 KINGS (Topglove, Supermax, Hartalega, Kossan) INCLUDING THE 2 ND TIER (Careplus, Comfort, Rubberex) INCLUDING THE RUBBER RELATED PRODUCTS (Adventa,) INCLUDING THE RUBBER DIPPING SYSTEMS (HLT, KSSC)
Will be blessed as SUPERMAX in this season,
from 01 September 2020 onwards, AS SUPERMAX WILL CLOAK IN TO MSCI Global Standard Indexes as of the close of 31 August 2020,
It is the MERDEKA DAY FOR ALL THE RUBBER GLOVE STOCKS, RUBBER RELATED STOCKS, RUBBER DIPPING LINES SYSTEMS STOCKS WILL BE THE FRIENDLY LEADER OF THE BLACK PANTHER PACK TO EXHIBIT LEADERSHIP WITH SUPERIOR QUALITY TO LIFT UP ALL THE ABOVE STOCKS THE FRIENDLY BIG BIG BIG WAVE WILL LIFT UP THE SMALLER BOATS
============================================ MSCI GLOBAL STANDARD INDEXES, SUB MSCI MALAYSIA INDEX MSCI MEANS Morgan Stanley Capital International Index
WHO WILL CLOAKED IN? SUPERMAX CORPORATION BHD KOSSAN RUBBER INDUSTRIES BHD
WHO WILL CLOAKED OUT? IJM CORP BHD +++++++++++++++++++++++++++++++++++++++++++++++
SUMMARY MSCI INDEXES
ARE THE MEASUREMENT OF STOCK MARKET PERFORMANCE IN A PARTICULAR AREA. LIKE OTHER INDEXES, SUCH AS DOW JONES INDUSTRIAL AVERAGE, S + P 500,
IT TRACKS THE PERFORMANCE OF THE STOCKS INCLUDED INTER RELATED INDEX ============================================= MSCI HISTORY
IN 1968, MORGAN STANLEY, published the Capital International Indexes, first indexes for market outside of the USA and in 1969,the MSCI DEVELOPED MARKETED Indexes were published.
In 1987, for the Emerging Market Index was published.
In 1996, MSCI ALL COUNTRY INDEXES. were published for developing markets and emerging markets. +++++++++++++++++++++++++++++++++++++++++++
SEE_Research Is it GREAT Is it AWESOME Is it AMAZING
ON THIS SPECIAL DAY, MERDEKA DAY OUR SUPERMAX, OUR KOSSAN
ARE CLOAKED INSIDE THE MSCI GLOBAL STANDARD INDEX /SUB MSCI MALAYSIA INDEX
TRULY MERDEKA WITH SUPERMAX WITH SUPERIOR SUPERMAX WITH SUPREME SUPERMAX
Posted by geary > Aug 31, 2020 1:57 PM | Report Abuse
PZOGRO In US, ppl buying Apple Tesla until stock split today’s also keep pushing higher; but Malaysian will normally do the other way. Buy before stock split and Sell after stock split! That’s Malaysian! Happy Merdeka! 31/08/2020 1:47 PM
For counter with high earnings growth...still have legs to run...plus there are final n special dividend...o:-)
Kids argued here and CEO of the 7 companies need to stand forward and explain for each and one of you? Based on your argument? That's kinda silly. By the way, for vaccine followers, quickly go grab your vaccine jabs now while stock last... Eh, not open yet ah? Or no dare? Come on, be our white mouse... You'll get rewarded from the vaccine-related stocks....
Coronavirus outbreak Alarm as FDA willing to issue Covid-19 vaccine before stringent safety testing
FDA under intensifying pressure from Trump, who wants to see a vaccine come on stream or ready to announce before the election Ed Pilkington in New York @edpilkington Sun 30 Aug 2020 21.12 BST
Public health experts have reacted with alarm to remarks by the head of the US Food and Drug Administration (FDA) that he might give the green light for a US Covid-19 vaccine before the normal clinical trial process had reached its conclusion.
As the US was on the verge of 6m coronavirus cases on Sunday, Stephen Hahn, the FDA commissioner, told the Financial Times in an interview published on Sunday that he was prepared to issue emergency use authorization for a Covid-19 vaccine before the end of Phase 3 human trials that put the drug through stringent testing for safety and efficacy.
He said the standard he would apply instead would be “that the benefit outweighs the risk in a public health emergency”.
Hahn told the newspaper that his decision would not be swayed by political pressure amid the febrile atmosphere of the upcoming US presidential election. “This is going to be a science, medicine, data decision. This is not going to be a political decision,” he said.
But several public health experts expressed their concern on Sunday about an apparent willingness to consider fast-tracking a vaccine outside what is considered the gold standard testing process.
The FDA has come under intensifying pressure in recent weeks from Donald Trump, who wants to see a vaccine come on stream or ready to announce before the November election, and has a public-private vaccine development funding program underway called Operation Warp Speed.
Trump has openly attacked the FDA, baselessly citing a supposed “deep state” within it of dragging its feet on the vaccine approval process, despite no evidence to support the latest version of a right-wing conspiracy theory that even one of its most enthusiastic, original Trump administration propagators, Steve Bannon, has dismissed.
The number of confirmed cases of Covid-19 was approaching 6m in the US by Sunday afternoon, according to figures from Johns Hopkins University, while recorded deaths stand at a catastrophic 182,612 – almost a quarter of all global fatalities.
Over the weekend California became the first state to pass 700,000 confirmed cases.
Since the beginning of the pandemic in January, Trump has consistently downplayed the severity of the crisis and sidelined scientists, including those at the FDA.
Hahn has been criticized for misleading the public about the efficacy of convalescent plasma treatment which takes blood plasma from Covid-19 survivors and injects it into sufferers.
At a White House media launch last week Hahn, standing beside Trump, said the plasma treatment would save 35 lives out of every 100 patients when in fact studies put the figure at 3 to 5 lives. He was forced to apologise.
Scientists and public health specialists were quick to issue warnings about Hahn’s comments about cutting short the vaccine trials.
Dr Angela Rasmussen, a virologist at New York’s Columbia University, said: “We absolutely cannot tolerate or accept an emergency authorization for any Covid-19 vaccine without reliable safety and efficacy data from phase three clinical trials”.
Writing on Twitter, she said it would be unethical to give the go-ahead before the trials had conclusively proved that both the safety and efficacy of the vaccine.
It would place “huge numbers of people at risk for massive potential harm” and would deal “a catastrophic blow to public confidence in both vaccines and the regulatory mechanisms in place”, she wrote.
Eric Topol of the Scripps Translational Research Institute said that it would take many months for the safety of the vaccine to be fully determined at trial, “irrespective of Stephen Hahn’s subservience to Trump… Any shortcuts will imperil the ultimate rollout of the vaccine and lose the public trust for getting immunized, which is already compromised.”
Hahn’s predecessor as head of the FDA, Scott Gottlieb, told CBS’s Face the Nation that “I don’t know what is meant by saying before the phase 3 trials are completed… They are going to wait for these trials to read out before they can make a decision about the efficacy of these vaccines.”
The news earlier this month that Russia had produced a vaccine was greeted with widespread skepticism because it had been approved and was being given to people, including one of Vladimir Putin’s daughters, before phase three trials
HOMEMALAYSIA As imported infections continue, Health Ministry braces for possible winter spike in Covid-19 cases
Monday, 31 Aug 2020 01:14 PM MYT
Health director-general Tan Sri Dr Noor Hisham Abdullah said a mutation of the Covid-19 virus has made it more infectious. — Bernama pic
PUTRAJAYA, Aug 31 — The Health Ministry (MOH) is already looking four months ahead by preparing for a possible spike of Covid-19 infections due to winter weather conditions in several other parts of the world.
Health director-general Tan Sri Dr Noor Hisham Abdullah although the country’s infection rate is now under control, developments in other countries, such as what happened in India, Korea, Japan, Spain and France that saw an increase in cases during cold weather conditions must be considered.
“So, our concern is that there would be an increase in cases during that period and due to this we have to make preparations,” he told Bernama when met after attending the National Day 2020 celebrations at Dataran Pahlawan Negara here today.
At the same time, Dr Noor Hisham said a mutation of the Covid-19 virus has made it more infectious and as such, he urged the people to always be on their guard and strictly comply with standard operating procedures (SOPs).
He said as there is still no proven vaccine in sight, the ministry would continue to carry out control measures.
“Through these measures, the people must comply with SOPs while on our part we prepare in terms of laboratory, clinics and hospitals in which if there is a case surge we would be able to control the situation,” he said.
Through its public healthcare system, Malaysia had been able to contain the pandemic through early detection of clusters, Dr Noor Hisham said.
“However, we will still need strong cooperation from the people when it comes to breaking the chain of Covid-19 infection,” he said. — Bernama
Related ArticlesIsmail Sabri: 253 arrested, 32 remanded for various RMCO violationsJapan considers tax reform to lure foreign financial firms, annual policy saysPAS spiritual leader likens minister who broke self-isolation to Quranic ‘hero’, blames Health, Foreign Ministries for negligence
981 Million - 15% discount = *** 834 Million *** profit Visibility for the next quarter (July to September) you can’t find in any other Bursa companies
SUPERMX is really the Best of the Best!!!
Note: ~ Other Companies ~ you Guess you Wish you Worry what will be the next Gloomy quarterly result during this difficult time *You worry Coronavirus 2nd wave, 3rd wave,…New Strains MUTATIONS, Re-Infections *You worry Syndicates sharks Pharma stocks Empty Talks vaccine news rumors Nothing approved by WHO yet NO PROFIT YET goreng trap investors *You worry Economic Downturn recession *You worry what RMCO extended what if MCO again *You worry Politics Instability delay projects delay of contracts award. After new election, minority weak government also headache, U-Turn, cancel contracts, etc. *You worry USA Election early November *You worry Trade War escalation *You worry Nasdaq bubble burst Tech stocks overvalued *You worry dividend stocks Stopped paying dividends *You worry Geopolitical conflicts Regional tension *You worry Oil Price CRASH again *You worry worldwide Coronavirus cases hit OVER 25 MILLIONS *You worry Autumn & Winter coming Seasonal Flu + Coronavirus = Twindemic
= SUPERMX = you can Calculate you can See Clearly Already what will be the next Superb another Record High quarterly result for Jul to Sep 2020 of SUPERMX from the Quarterly Report and Briefing Report. The management already breakdown all the costs showed you the $$$ HIGHER and HIGHER ASP $$$ SOLD OUT CAPACITY $$$ HUGE ORDER BOOK $$$ LONG DELIVERY LEAD TIME $$$ EXTREMELY POWERFUL OBM + OWN DISTRIBUTION NETWORK Streamlined Business Model removed all the middlemen $$$ DOUBLE INCOME STREAMS $$$ SUSTAINABLE STRONG EARNINGS EVEN POST-COVID19 *NO WORRIES $$$ 1 for 1 Bonus Issue $$$ 1 for 45 Share Dividend
NBC News COVID-19 reinfection reported in Nevada patient, researchers say Erika Edwards and Akshay Syal August 29, 2020, 3:52 AM GMT+8
A Nevada man appears to be the nation's first confirmed case of COVID-19 reinfection, researchers say.
The case is detailed in an online preprint, a study that has not yet been peer reviewed before officially being published.
Full coverage of the coronavirus outbreak
The case involves a 25-year-old man living in Reno, Nevada, who first tested positive for COVID-19 in mid-April. He recovered, but got sick again in late May. The second time around, his illness was more severe. Researchers reported that genetic sequencing of the virus revealed that he had been infected with a slightly different strain, indicating a true reinfection.
It's still unclear why the patient was reinfected. The cause could lie in his immune system, the virus itself, or a combination of the two.
Mark Pandori, director the Nevada State Public Health Laboratory and one of the authors of the report, stressed that reinfection with the coronavirus appears to be rare. This is the first instance reported in the U.S. among the nation's nearly 6 million cases so far, and "may not be generalizable" to the public, Pandori said.
Still, he urged caution. "If you've had it, you can't necessarily be considered invulnerable to the infection" again, said Pandori, who is also an associate professor of pathology and lab medicine at the University of Nevada, Reno School of Medicine.
"The evidence so far suggests that if you've been infected and recovered, then you're protected for some period of time," Dr. Ashish Jha, director of the Harvard Global Health Institute, said. "We don't know how long, and we're going to find individual cases of people for whom that's not true."
Indeed, on Monday, a case of COVID-19 reinfection was reported in Hong Kong -- the first such confirmation of reinfection during the pandemic. Two European patients, one in Belgium and one in the Netherlands, were also reported this week to have been reinfected with the virus.
But in those instances, the patients did not get sick the second time around, or they developed much milder forms of the illness than their first infection.
"You'd expect the second time around people to have much milder or ideally no symptoms," Jha said. That's because the immune system should be able to mount a more robust response, and the Hong Kong case was "completely consistent with that."
Download the NBC News app for full coverage of the coronavirus outbreak
In the Nevada case, however, the man got sicker the second time. When he was first infected, he had typical symptoms for the coronavirus: headache, cough, sore throat, nausea and diarrhea. Within about 10 days, the symptoms cleared up, and he tested negative for the virus.
But a month later, on May 28, he started feeling sick again, experiencing dizziness as well as the previous symptoms.
The illness did not clear up quickly this time. Within a week, his blood oxygen level fell dangerously low. He needed help breathing, and was hospitalized. Once again, the man tested positive for SARS-CoV-2, the virus that causes COVID-19.
"That's very concerning," Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, said.
Story continues
RELATED STORIES FOX News Videos Nevada confirms first case of coronavirus reinfection in the US
21h ago Yahoo News First confirmed case of COVID-19 reinfection is ‘not surprising,’ doctors say
Miami Herald Florida confirms 3,197 new COVID cases and 148 deaths as positivity rate trends down
2d ago Deadline L.A. Coronavirus Report: Public Health Notes Decline In Daily Hospitalizations, Confirms 10 New Deaths And 1,030 New Cases – Update
The barrier of entry into Glove Industry is much higher than making masks : 1. Higher costs to manufacture glove 2. High quality requirements by hospitals. 3. Tough certification process 4. Longer time required to set up glove lines 5. Branding is important. 6. Raw materials supply are very limited and not easily available for new entries
Time to wake up dy glove holders, dont make directors so rich until they become billionaire, stop feeding the rich and focus on the vaccine so people can go back to normal life
Petronas and LG Chem JV to build manufacturing plant to make nitrile butadiene latex to supply to Glove companies. Plant construction starts 2021 and production starts 2023.
___ BUSINESS DEALS Malaysia's Petronas and LG Chem to build glove material plant State energy firm moves into nitrile as COVID-19 spurs demand for protective gear
The manufacturing plant is slated to begin production in 2023 to tap the growing market for rubber gloves, in which Malaysia is already a global leader. Major manufacturers in the country include Top Glove, Hartalega and Supermax.
Construction of the plant will begin in 2021 at Petronas' petrochemical complex in the southern state of Johor, and it will have an initial production capacity of 200,000 tons of nitrile butadiene latex a year, the company's chemicals arm, Petronas Chemicals, said in a statement on Monday. No investment values were disclosed.
Nitrile butadiene latex is a synthetic rubber that uses butadiene as the main feedstock and is a core raw material for making nitrile gloves, which are widely used in health care and the food industry. Nitrile gloves are gaining traction against their natural rubber counterparts thanks their improved durability and chemical-resistance features.
Recently, the use of nitrile gloves has surged amid efforts to prevent the spread of Covid-19 and other infections. Demand is growing at more than 10% a year on average and nitrile gloves are expected to account for 70% of the entire latex glove market in 2024.
Petronas Chemicals says the partnership with LG Chem is timely given the steady growth in demand for nitrile gloves globally, and will help create new revenue streams and open up new markets by the two companies' resources. The plant is will offer various grades and new applications of butadiene latex, as well as develop high-value-added products through research and development and investment, the company added.
"It provides a compelling entry point into the growing nitrile butadiene latex-based products and enables Petronas Chemicals to enhance its presence in attractive end-markets, especially for personal care and healthcare, mainly in the Asia-Pacific region," Petronas Chemicals Managing Director Sazali Hamzah said.
For Petronas Chemicals specifically, Sazali said the partnership with LG Chem will further strengthen the pursuit of its growth agenda following the acquisition of a silicone player last year. "With more specialty chemicals in our portfolio, we are moving into segments with higher growth potential," he said.
In 2017, Petronas inked an agreement with Saudi Arabian Oil Company, also known as Saudi Aramco, with the latter investing $7 billion for a 50% stake in refinery and cracker plants in a $27 billion refineries and petrochemical integrated complex in Johor.
Petronas Chemicals, which released its second-quarter financial results last week, saw its net profit for the three-month period fall 83% to 186 million ringgit from 1.11 billion ringgit registered in the second quarter of 2019. The company blamed the weak performance on lower plant utilization rates and decreased production volume and sales volumes, all related to the aftermath of the coronavirus pandemic, which forced Malaysia to impose a three-month lockdown.
Revenue for the three-month also fell 26% to 3.17 billion ringgit from 4.33 billion ringgit a year ago.
Email address READ NEXT Economy Malaysian GDP plunge fuels talk of post-COVID economic remodeling Coronavirus Japan's 'medical diplomacy' in ASEAN aims to sap China clout Coronavirus Singapore-Malaysia border reopening restores economic lifeline Coronavirus Japan, Malaysia may resume travel in early Sept. for expatriates Environment Oceans fall victim to COVID as masks end up as litter Economy
NIKKEI ASIAN REVIEW
About UsContact UsSitemapHelpTerms Of UseCopyrightPrivacy & Cookie PolicyAdvertising Nikkei Inc.
China glove industry is not as competitive as Malaysia's World Class Glove Companies. Partly this is due to limited raw material supply and supply network inadequacy in China. Moreover, the Western countries especially USA always prefer to less rely on China
Tanlp just shared what I just saw on Reuters, would that scare off the vaccine investors tomorrow? Nevermind bout glove counters, but will Vaccine counters limit down or gap down tomorrow? Ha Jackthejeep talked making vaccine like planting mango tree at our backyard... Ha
OPR TO CUT BY 25 BASIS POINT FROM CURRENT 1.75% TO 1.50%? Bank Negara Malaysia (BNM) is expected to make one final 25 basis point (bps) cut in the Overnight Policy Rate (OPR) as early as in the central bank’s next Monetary Policy Committee (MPC) meeting on Sept 10, 2020 in anticipation of an arduous economic recovery path ahead.
Bank Negara to announce opr cut again... that means more retailer money going into Bursa.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
MQ Trader 14672 views | 13 d ago
0:43
M & A Value Partners IPO Equity Fund
MQ Trader 4787 views | 1 mo ago
0:16
MQ Market Updates - 3 September 2024
MQ Trader 124 views | 20 h ago
0:15
MQ Market Updates - 2 September 2024
MQ Trader 105 views | 1 d ago
0:17
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
KK
1,368 posts
Posted by KK > 2020-08-30 19:12 | Report Abuse
https://www.thestar.com.my/news/world/2020/08/30/russia039s-coronavirus-infection-tally-climbs-to-near-one-million